Futures Mixed As Pfizer, Procter & Gamble Weigh on Market

Futures traded slightly lower early Tuesday as investors worked through disappointing results from Procter & Gamble that offset strong results from pharmaceutical company Pfizer. As of 8:25 a.m. ET, the Dow Jones Industrial Average futures were down 11 points, to 10606, the S&P 500 index futures were down 2.4 points to 1,119.40 and the Nasdaq 100 futures lost 0.25 points to 1894.00. Shares of the consumer giant P&G PG were down 3% in pre-market trading following P&G reporting a profit of 71 cents a share, two cents below analysts' expectations, and the company's sales of $18.9 billion also falling short of estimates. The company said increased marketing was the primary reason for the earnings shortfall this quarter, however the company did also cite lingering consumer weakness in the form of consumers trading down to lower-cost brands. Meanwhile shares of drug company Pfizer PFE advanced 3% following results that came well ahead of expectations. The producer of Lipitor posted an adjusted profit of $0.62 per share, beating estimates by 10 cents, while revenue of $17.3 billion also exceeded estimates of $16.65 billion. To read the rest, head over to FOX Business.